- Home
- ONB vs CORT Comparison
ONB vs CORT Comparison
Compare ONB & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONB
- CORT
- Stock Information
- Founded
- ONB 1834
- CORT 1998
- Country
- ONB United States
- CORT United States
- Employees
- ONB N/A
- CORT N/A
- Industry
- ONB Major Banks
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- ONB Finance
- CORT Health Care
- Exchange
- ONB Nasdaq
- CORT Nasdaq
- Market Cap
- ONB 8.1B
- CORT 7.6B
- IPO Year
- ONB N/A
- CORT N/A
- Fundamental
- Price
- ONB $22.66
- CORT $72.87
- Analyst Decision
- ONB Buy
- CORT Strong Buy
- Analyst Count
- ONB 10
- CORT 4
- Target Price
- ONB $26.60
- CORT $139.00
- AVG Volume (30 Days)
- ONB 2.8M
- CORT 658.4K
- Earning Date
- ONB 10-21-2025
- CORT 10-29-2025
- Dividend Yield
- ONB 2.47%
- CORT N/A
- EPS Growth
- ONB N/A
- CORT N/A
- EPS
- ONB 1.67
- CORT 1.11
- Revenue
- ONB $1,893,728,000.00
- CORT $716,080,000.00
- Revenue This Year
- ONB $44.99
- CORT $30.62
- Revenue Next Year
- ONB $15.31
- CORT $37.68
- P/E Ratio
- ONB $13.55
- CORT $65.38
- Revenue Growth
- ONB 9.52
- CORT 25.71
- 52 Week Low
- ONB $16.83
- CORT $35.45
- 52 Week High
- ONB $24.49
- CORT $117.33
- Technical
- Relative Strength Index (RSI)
- ONB 55.24
- CORT 56.90
- Support Level
- ONB $22.29
- CORT $67.32
- Resistance Level
- ONB $23.32
- CORT $72.52
- Average True Range (ATR)
- ONB 0.49
- CORT 2.19
- MACD
- ONB -0.03
- CORT 0.36
- Stochastic Oscillator
- ONB 40.00
- CORT 74.30
About ONB Old National Bancorp
Old National Bancorp with almost $10 billion in assets following its latest acquisition, Old National Bancorp is a financial services bank holding company headquartered in Indiana. Based in Evansville, Ind., Old National owns multiple financial services operations in Indiana, Illinois, and Kentucky. The company provides a group of similar community banking services, including such products and services as commercial, real estate, and consumer loans; deposits; and brokerage, trust, and investment advisory services.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.